Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy
Cell Proliferation · 2025-03 · 58 (3)
DOI: 10.1111/cpr.13779 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cell Proliferation, online erschienen am 03.12.2024. Verfasst von Yiming Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, China. Hauptthemen laut MEDLINE: Ferroptosis, Osteoarthritis. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 157 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Postdoctoral Research Program, the Major Basic Research Project of the Natural Science Foundation of Shandong Province, the Taishan Scholars Program of Shandong Province.
Abstract (Originalsprache)
Osteoarthritis (OA) is a chronic, degenerative joint disease primarily characterised by damage to the articular cartilage, synovitis and persistent pain, and has become one of the most common diseases worldwide. In OA cartilage, various forms of cell death have been identified, including apoptosis, necroptosis and autophagic cell death. Ever‐growing observations indicate that ferroptosis, a newly‐discovered iron‐dependent form of regulated cell death, is detrimental to OA occurrence and progression. In this review, we first analyse the pathogenetic mechanisms of OA by which iron overload, inflammatory response and mechanical stress contribute to ferroptosis. We then discuss how ferroptosis exacerbates OA progression, focusing on its impact on chondrocyte viability, synoviocyte populations and extracellular matrix integrity. Finally, we highlight several potential therapeutic strategies targeting ferroptosis that could be explored for the treatment of OA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Genetics and Cell Biology, School of Basic Medicine, Qingdao University, Qingdao, China.
- Department of Reproductive Medicine, The Affiliated Hospital of Qingdao University, Qingdao, China.
- Department of Hematology, Rizhao People's Hospital, Rizhao, China.
- Department of Hematology, The Affiliated Hospital of Qingdao University, Qingdao, China.
- International Joint Laboratory of Medicinal Food R&D and Health Products Creation/Biological Engineering Technology Innovation Center of Shandong Province, Heze Branch of Qilu University of Technology (Shandong Academy…
- Key Laboratory of Basic and Translational Research on Immune-Mediated Skin Diseases; Jiangsu Key Laboratory of Molecular Biology for Skin Diseases and STIs, Institute of Dermatology, Chinese Academy of Medical Sciences…
ORCID-Profile: Xiao Hu, Zheng Wang
Förderung
- Chinese Postdoctoral Research Program
- the Major Basic Research Project of the Natural Science Foundation of Shandong Province
- the Taishan Scholars Program of Shandong Province
- Natural Science Foundation of Shandong Province
- National Natural Science Foundation of China
- Industry Integration Innovation Pilot Project from Qilu University of Technology (Shandong Academy of Sciences)
- Shandong Academy of Sciences
Zitieren
APA
Zhang, Y., Li, J., Liu, J., Gao, Y., Li, K., Zhao, X., Liu, Y., Wang, D., Hu, X., & Wang, Z. (2025). Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy. Cell Proliferation, 58(3). https://doi.org/10.1111/cpr.13779
Vancouver
Zhang Y, Li J, Liu J, Gao Y, Li K, Zhao X, et al. Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy. Cell Proliferation. 2025;58(3). doi:10.1111/cpr.13779
BibTeX
@article{Zhang2025,
author = {Zhang, Yiming and Li, Jing and Liu, Jiane and Gao, Yan and Li, Kehan and Zhao, Xinyu and Liu, Yufeng and Wang, Daijie and Hu, Xiao and Wang, Zheng},
title = {Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy},
journal = {Cell Proliferation},
year = {2025},
volume = {58},
number = {3},
doi = {10.1111/cpr.13779}
}
EUVIMED